Basic Information | Post buying leads | Suppliers |
Name |
Frovatriptan succinate |
EINECS | N/A |
CAS No. | 158930-09-7 | Density | N/A |
PSA | 146.50000 | LogP | 2.55440 |
Solubility | N/A | Melting Point |
N/A |
Formula | C18H23N3O5 | Boiling Point | 515.2 °C at 760mmHg |
Molecular Weight | 361.3923 | Flash Point | 265.4 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1);1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1);VML 251;1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1);SB-209509ax;Butanedioic acid,compounds,compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1Hcarbazole- 6-carboxamide (1:1); |
The Frovatriptan succinate is an organic compound with the formula C18H23N3O5. The IUPAC name of Frovatriptan succinate is butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide. With the CAS registry number 158930-09-7, it is also named as 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1).
The other characteristics of this product can be summarized as: (1)H-Bond Donor: 5; (2)H-Bond Acceptor: 6; (3)Rotatable Bond Count: 5; (4)Tautomer Count: 5; (5)Exact Mass: 361.163771; (6)MonoIsotopic Mass: 361.163771; (7)Topological Polar Surface Area: 146; (8)Heavy Atom Count: 26; (9)Formal Charge: 0; (10)Complexity: 426; (11)Isotope Atom Count: 0; (12)Defined Atom StereoCenter Count: 1; (13)Undefined Bond StereoCenter Count: 0; (14)Covalently-Bonded Unit Count: 2.
People can use the following data to convert to the molecule structure.
1. Smiles:C1[C@H](Cc2c(C1)[nH]c1c2cc(cc1)C(=O)N)NC.C(=O)(O)CCC(O)=O
2. InChI:InChI=1/C14H17N3O.C4H6O4/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8)/t9-;/m1./s1